Alexandra Moros

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · The Lancet Regional Health - Europe · 2023 · 32 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

Antonio Barreiro, Antoni Prenafeta, G. Bech-Sàbat et al. · iScience · 2023 · 27 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · medRxiv · 2022 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

Lorna Leal, Judit Pich, Laura Ferrer et al. · npj Vaccines · 2023 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17